As of 28 Aug 2026, Norris Medicines Ltd share price is ₹15.64. The stock opened at ₹15.64 and had closed at ₹15.57 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹12.00 and a high of ₹19.63. In terms of performance, Norris Medicines Ltd share price has increased by 15.51% over the past six months and has decreased by 2.31% over the last year.
Norris Medicines Charts
Norris Medicines Ltd Overview
About Norris Medicines
Norris Medicines manufactures generic pharmaceutical tablets, capsules, syrups, and suspension form products. The Company produces a range of antibiotic, anti-inflammatory, and analgesic products, as well as products for nutrition, anxiety, diabetes, and
Norris Medicines Ltd Historical Performance
Norris Medicines Ltd Fundamental Analysis
Norris Medicines Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 0.92 | 1.43 | 3.27 | 2.00 | 1.48 |
| EBITDA | -0.29 | 0.32 | 0.95 | -0.49 | -0.08 |
| Net Profit | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 |
| EPS | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 |
Norris Medicines Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 50.45 |
| MACD | 0.10 |
| 20-Day SMA | 15.28 |
Norris Medicines Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Norris Medicines Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Norris Medicines Ltd today is ₹15.64 on NSE and ₹15.64 on BSE.
- The 52-week high of Norris Medicines Ltd is ₹19.63, while the 52-week low is ₹12.00.
- The current market capitalisation of Norris Medicines Ltd is approximately ₹16 crore.
- The P/E (Price-to-Earnings) ratio of Norris Medicines Ltd is -42.27. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Norris Medicines Ltd is 0.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Norris Medicines Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Norris Medicines Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Norris Medicines Ltd has delivered a return of approximately 31.54%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Norris Medicines Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 34.01% promoters, 0.00% FIIs, 0.07% DIIs, and 20.78% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
